Skip to main content
. 2016 Jul 5;3:29. doi: 10.3389/fmed.2016.00029

Table 3.

Nausea and vomiting outcome variables (0–120 h).

Outcome variables 0–2 h
24–48 h
24–72 h
24–96 h
24–120 h
Aprepitant Ondansetron Aprepitant Ondansetron Aprepitant Ondansetron Aprepitant Ondansetron Aprepitant Ondansetron
Number of subjects 48 47 48 47 48 47 48 47 48 47
PONV, n (%) 15 (31.3) 17 (36.2) 13 (27) 8 (17) 16 (33) 8 (17) 16 (33) 16 (34) 17 (35) 16 (34)
Vomiting, n (%) 4 (8.3) 6 (12.8) 1 (2.1) 4 (8.5) 2 (4.2) 4 (8.5) 2 (4.2) 4 (8.5) 3 (6.3) 4 (8.5)
Worst vomiting score, median (IQR) 1.5 (1, 2) 3 (3, 3) 1 (1, 1) 2 (2, 2.5) 1.5 (1, 2) 2 (2, 3) 1.5 (1, 2) 2.5 (2, 3) 1 (1, 2) 2.5 (2. 3)
Any nausea incidence, n (%) 15 (31.3) 17 (36.2) 12 (25) 8 (17) 15 (31.3) 8 (17) 15 (31.3) 16 (34) 16 (33.3) 16 (34)
Significant nausea incidence (A score ≥4 on the VRS), n (%) 3 (10) 7 (23) 11 (22.9) 7 (14.9) 16 (17) 9 (10) 21 (15) 15 (11) 25 (13) 17 (9)
Worst nausea score, median (IQR) 6 (3, 5.8) 7 (5, 10) 6 (5, 8) 7 (6, 7.5) 6.5 (4.5, 8) 7 (6, 9) 7 (5, 8) 6 (4, 7) 6 (4, 8) 7 (6, 9)
Rescue antiemetics, n (%) 3 (6) 9 (19) 5 (10) 3 (6) 6 (12.5) 3 (6) 6 (12.5) 7 (15) 7 (15) 8 (17)
Postoperative opioid consumption (oral morphine mg), median (IQR) NA NA 41.2 (15.0, 103.5) 46.2 (15.0, 84.0) 45.0 (15.0, 105.0) 38.7 (15.0, 69.0) 45.0 (15.0, 92.5) 40.0 (15.0, 69.0) 40.0 (15.0, 90.0) 38.7 (18.0, 72.0)

VRS, verbal rating scale; IQR, interquartile range; %, percentage; 0 hour, End of Surgery (closure time).